Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01143142 · ClinicalTrials.gov registry record · NA

Vax Facts Human Papillomavirus (HPV): Study of a Computer-based Tailoring System and Mothers' Intentions to Vaccinate Their Daughters Against HPV

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
70
Enrollment target

NCT01143142: Completed NA study, sponsored by University of Michigan.

NCT01143142 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01143142, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target

Study Summary

The goal of this study is to determine whether a two-page print brochure that delivers individually tailored educational messages about the Human papillomavirus (HPV) vaccine increases HPV vaccine-hesitant mothers' intentions to have their adolescent daughters vaccinated against HPV.

Primary Outcome

Mother will rate her intention to have her daughter vaccinated against HPV using a Likert scale before and after the intervention. The scale ranges from 0-11 with higher numbers representing more positive intentions to vaccinate against HPV, and 5 being neutral intentions (i.e. neither positive nor negative). In this assessment we use this 11-point scale to assess vaccination before and after viewing the educational materials. The difference pre and post intervention in vaccination intention is

Interventions

  • BEHAVIORAL Computer-based tailoring system

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2010-06
Est. Completion 2011-10
Phase NA
University of Michigan

1,327 total trials

What the finished NCT01143142 record still lists

NCT01143142 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Computer-based tailoring system is the first listed.

NCT01143142 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01143142 about?

NCT01143142 is a clinical study titled "Vax Facts Human Papillomavirus (HPV): Study of a Computer-based Tailoring System and Mothers' Intentions to Vaccinate Their Daughters Against HPV". The goal of this study is to determine whether a two-page print brochure that delivers individually tailored educational messages about the Human papillomavirus (HPV) vaccine increases HPV vaccine-hesitant mothers' intentions to have their adolescent daughters vaccinated against HPV.

What is the current status of trial NCT01143142?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2010-06. Estimated completion is 2011-10.

What interventions are being tested in trial NCT01143142?

The interventions under investigation include: Computer-based tailoring system (BEHAVIORAL).

Who is sponsoring clinical trial NCT01143142?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01143142's enrollment target sits among peer trials

70 1103rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01143142, the US trial registry maintained by the National Library of Medicine. NCT01143142 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.